Medical Technology and Practice Patterns Institute, Bethesda, MD.
Department of Population Medicine, Harvard Medical School, Boston, MA.
Health Serv Res. 2018 Jun;53(3):1900-1918. doi: 10.1111/1475-6773.12718. Epub 2017 May 30.
To compare the effectiveness of dynamic anemia management strategies by applying the parametric g-formula to electronic health records.
DATA SOURCE/STUDY SETTING: Patients with end-stage renal disease from the US Renal Data System who had congestive heart failure or ischemic heart disease and were undergoing hemodialysis in outpatient dialysis facilities between 2006 and 2010.
We explicitly emulated a target trial of three erythropoietin dosing strategies (aimed at achieving a low, middle, or high hematocrit) and estimated the observational analog of the per-protocol effect.
Of 156,945 eligible patients, 41,970 died during the 18-month follow-up. Compared to the low-hematocrit strategy, the estimated risk of death was 4.6 (95% CI 4.4-4.9) percentage points higher under the high-hematocrit strategy and 1.8 (95% CI 1.7-1.9) percentage points higher under the mid-hematocrit strategy. The corresponding risk differences for a composite outcome of death and myocardial infarction were similar.
An explicit emulation of a target trial using electronic health records, combined with the parametric g-formula, allowed comparison of real-world dynamic strategies that have not been compared in randomized trials.
通过应用参数 g 公式对电子健康记录进行分析,比较动态贫血管理策略的效果。
数据来源/研究范围:2006 年至 2010 年间,在美国肾脏数据系统中患有充血性心力衰竭或缺血性心脏病且正在接受门诊透析设施血液透析的终末期肾病患者。
我们明确模拟了三种促红细胞生成素给药策略的目标试验(旨在实现低、中或高血细胞比容),并估计了观察性协议效果的模拟。
在 156945 名符合条件的患者中,有 41970 人在 18 个月的随访期间死亡。与低血细胞比容策略相比,高血细胞比容策略下的死亡风险估计高出 4.6(95%CI 4.4-4.9)个百分点,中血细胞比容策略下的死亡风险估计高出 1.8(95%CI 1.7-1.9)个百分点。死亡和心肌梗死复合结局的相应风险差异也相似。
使用电子健康记录进行明确的目标试验模拟,并结合参数 g 公式,允许比较尚未在随机试验中比较的真实世界动态策略。